Astrazeneca Pharma is in the limelight today morning, recording volumes of over 24 times, up over 11 times at Rs.821 and this is after having hit an intra day high at Rs.846.80.

The company shot into the green after it posted a turnaround in its Q3 performance, with a net profit at Rs.1.51 crore compared to a net loss of Rs.18 crore in Q3FY13. Net sales rose 14% at Rs.119 crore. The improvement in sales and the 3.25% drop in operating expenses are what helped turnaround.